Xanaflu Tetra Saison 2024/2025

Xanaflu Tetra Saison 2024/2025 is a quadrivalent influenza vaccine designed to protect against four influenza virus strains. It is administered via intramuscular or subcutaneous injection for seasonal flu prevention. This vaccine is suitable for adults and children aged 6 months and older. Always consult a healthcare provider for personalized advice.

Xanaflu Tetra Saison 2024/2025 is used to help prevent influenza, commonly known as the flu. It protects against four influenza virus strains, including two influenza A and two influenza B viruses. The vaccine is updated annually to match circulating flu viruses. It is recommended for individuals seeking seasonal flu protection.

After vaccination, the body develops immunity to the influenza viruses contained in the vaccine. This immunity helps reduce the risk of contracting the flu or experiencing severe symptoms if infected. Common effects may include mild soreness at the injection site or low-grade fever. These effects are generally temporary and indicate the body’s immune response.

Store the vaccine at 2°C to 8°C and protect it from light. Do not freeze. Before administration, check the vaccine vial for any discoloration or particles. Ensure the vaccine is administered by a healthcare professional. Inform your healthcare provider of any allergies or medical conditions prior to vaccination.

Xanaflu Tetra Saison 2024/2025 may interact with immunosuppressive therapies, reducing its effectiveness. Avoid receiving the vaccine if you have a severe fever or acute illness. Discuss any recent vaccinations or medications with your healthcare provider. Live vaccines should not be administered within 4 weeks of this vaccine.